| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LANNETT CO INC | Director | Common Stock | 587,145 | $475,587 | $0.8100 | 10 Nov 2022 | Direct |
| VYNE Therapeutics Inc. | Director | Common Stock | 51,472 | $150,298 | $2.92 | 15 Jan 2025 | Direct |
| VYNE Therapeutics Inc. | Director | Stock Option (right to buy) | 20,000 | 12 Dec 2025 | Direct |